Advances in molecular diagnostics of myeloproliferative disorders

Brijesh Arora, Ayalew Tefferi

Research output: Contribution to journalReview article


Incremental advances in the molecular pathogenesis of myeloproliferative disorders (MPDs) have had a substantial impact on clinical practice in terms of both diagnosis and treatment. An array of novel molecular methods are being developed and integrated into the current battery of tests for diagnosis and monitoring of treatment response. Primarily, subjective clinico - histologic approaches to diagnosis are being replaced by more objective semimolecular diagnostic algorithms. Furthermore, identification of disease-specific molecular markers has facilitated the development of small-molecule drugs for targeted therapy. This review provides an overview of MPDs with emphasis on molecular diagnostic tests and their incorporation into contemporary diagnostic and therapeutic algorithms.

Original languageEnglish (US)
Pages (from-to)65-80
Number of pages16
JournalExpert Opinion on Medical Diagnostics
Issue number1
StatePublished - Sep 1 2007



  • JAK2
  • diagnosis
  • molecular tests
  • myeloproliferative disorders

ASJC Scopus subject areas

  • Biomedical Engineering
  • Molecular Medicine
  • Biochemistry, medical

Cite this